Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Open in API
Filings indexed 1,575 across all filing types
Latest filing 2023-08-09 Investor Presentation
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Please find attached Investor Presentation.
Investor Presentation Classification · 100% confidence The document is dated 9th August 2023 and is addressed to stock exchanges (BSE and NSE) with a subject line indicating it is an "Investor Presentation" under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The text explicitly states that an investor presentation is attached and also hosted on the company's website. The content includes detailed financial performance data for Q1 FY 2023-24, including revenue, EBITDA, PAT, segment performance, and business highlights. The document is about 15,000 characters long, which is substantial and contains detailed financial and operational data, not just a brief announcement. The presence of forward-looking statements, segment-wise financials, and detailed commentary on business performance aligns with the characteristics of an Investor Presentation. Therefore, this document is best classified as an Investor Presentation (IP).
2023-08-09 English
Kindly find attached update on sale of SSAIL
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding disclosures under Regulation 30 of the SEBI Listing Regulations. It discusses updates on a share purchase agreement transaction involving the sale of the company's investment in a subsidiary, extension of the long stop date for the transaction, and approval of capacity enhancement and expansion projects. The document is dated 7th August 2023 and is signed by the Company Secretary. It is a regulatory announcement informing the market about ongoing corporate actions and board decisions, rather than a full financial report, earnings release, or detailed management discussion. The content fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure under SEBI regulations and does not contain financial statements or detailed financial analysis.
2023-08-07 English
Diversification/Disinvestment
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Regulations, which pertains to continuous disclosure obligations for listed companies in India. It reports on updates related to a share purchase agreement and transaction progress, capacity enhancement approval by the Board of Directors, and expansion plans for new chemical products. The document is addressed to stock exchanges and is an announcement of corporate actions and board decisions rather than a full financial report or detailed management discussion. It is relatively short (4164 characters) and serves as a regulatory announcement of material events and board resolutions. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-08-07 English
Kindly find attached update on Diversification/Disinvestment, Capacity Addition, Expanding facility for new value added Chemical Products.
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Regulations, which pertains to continuous disclosure obligations for listed companies in India. It reports on updates related to a share purchase agreement, extension of a transaction completion date, and approval of capacity enhancement and expansion projects. The document is addressed to stock exchanges and is an announcement of corporate actions and updates rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. The length is 4164 characters, which is relatively short and consistent with an announcement. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it relates to transaction progress and capacity expansion financing plans.
2023-08-07 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Regulations, which pertains to continuous disclosure obligations for listed companies in India. It reports on updates related to a share purchase agreement and transaction progress, capacity enhancement approval by the Board of Directors, and expansion plans for new chemical products. The document is addressed to stock exchanges and is an announcement of corporate actions and board decisions rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis but rather updates on corporate transactions and board approvals. The document length is 4164 characters, which is relatively short and consistent with a regulatory announcement. Therefore, the document fits best under the category of Capital/Financing Update (CAP), as it involves updates on a significant transaction (sale of subsidiary shares) and capacity expansion financing plans.
2023-08-07 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement dated 7th August 2023 from India Glycols Limited regarding the outcome of a Board Meeting. It specifically mentions the approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2023. The document includes detailed financial tables with income, expenses, profit, segment revenue, and other financial metrics for the quarter and previous periods. It also references a Limited Review Report of Statutory Auditors, which is typical for quarterly financial disclosures. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification, but contains actual financial statements and analysis for the quarter.
2023-08-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.